Concepedia

David Mabon

DM

Statistics

Publications

3

Citations

94

H-Index

3

Active since

2015

Affiliations

Teva Pharmaceuticals (Australia)(Current)

Teva Pharmaceuticals (United States)

David Mabon is an author at Teva Pharmaceuticals (Australia) specializing in asthma, immune regulation, and allergy.

ORCID

Top concepts

Publications per year

2015–2019

3

Publications

3

An anti-TL1A antibody for the treatment of asthma and inflammatory bowel disease

Adam W. Clarke, Lynn D. Poulton, Doris Shim et al. · mAbs · 2018 · 53 citations · Full text

, , +17

Higher Binding Affinity and <i>In Vitro</i> Potency of Reslizumab for Interleukin-5 Compared With Mepolizumab

Mark T. Liddament, Jean Husten, Tanya Estephan et al. · Allergy Asthma and Immunology Research · 2019 · 25 citations · Full text

Potent neutralizing anti-CD1d antibody reduces lung cytokine release in primate asthma model

Jonathan K. Nambiar, Adam W. Clarke, Doris Shim et al. · mAbs · 2015 · 16 citations · Full text

, , +25

1–3 of 3